Orange City — Main Site
Our main clinical trial site anchors research operations for Central Florida. Outpatient study visits across endocrinology, pulmonology, psychiatry, and internal medicine run here, supported by an in-house regulatory department and a certified sample-processing laboratory.
What happens here
- 4 treatment rooms and 5 examination rooms
- Full-service on-site regulatory department
- Certified sample-processing lab (refrigerated centrifuges, −70°C and −20°C storage)
- On-site pharmacy with laminar flow hood for investigational product
- Bilingual English / Spanish study team
Studies enrolling at this location
Type 2 Diabetes with Obesity
Evaluating a new investigational therapy for adults with Type 2 Diabetes and obesity — measuring weight loss, metabolic health, and glycemic control.
See study →COPD with Type 2 Inflammation
Testing Depemokimab — an investigational long-acting anti–IL-5 therapy — to reduce exacerbations in adults with moderate-to-severe COPD.
See study →Idiopathic Short Stature (ISS) Growth Study
Evaluating Vosoritide, an investigational therapy designed to support bone growth and improve height outcomes in children with Idiopathic Short Stature.
See study →Major Depressive Disorder — Relapse Prevention
Testing Brenipatide alongside standard antidepressant therapy to delay or prevent relapse in adults currently in remission from MDD.
See study →Adults Living with Obesity (Without Diabetes)
Clinical research evaluating weight management for adults living with obesity who do not have a diabetes diagnosis.
See study →Type 2 Diabetes with Overweight or Obesity (VESPER-5)
A Phase 3 study (VESPER-5) of an investigational ultra-long-acting GLP-1 receptor agonist for adults with overweight or obesity and Type 2 Diabetes.
See study →Type 2 Diabetes with Obesity (AMAZE 8)
An investigational treatment study (AMAZE 8) for adults living with Type 2 Diabetes and overweight or obesity.
See study →Tardive Dyskinesia
A clinical research study of an investigational treatment for adults with tardive dyskinesia — involuntary, repetitive movements often linked to long-term use of certain psychiatric medications.
See study →Tardive Dyskinesia — Valbenazine Study
A Phase 4, open-label study of valbenazine for adults with tardive dyskinesia who remain symptomatic on deutetrabenazine or after stopping a prior VMAT2 inhibitor.
See study →Getting here
2541 South Volusia Ave., Suite 100, Orange City, FL 32763. Open in Maps ↗
Every study at this location runs under independent IRB oversight and ICH Good Clinical Practice standards.